STAT

Up and down the ladder: The latest comings and goings

Everyone wants to know who is coming and going. Here's what happened this week in biopharma.

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s. Don’t be shy. Everyone wants to know who is coming and going.

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da STAT

STAT1 min lettiMedical
STAT Plus: Pharmalittle: Pharma Showers State Legislators With Money; FDA Approves The First Drug For Ebola
Well over one-quarter of all state lawmakers nationwide have accepted money from the pharmaceutical industry since the beginning of 2019.
STAT1 min lettiMedical
STAT+: Pharmalittle: Serum Institute Threatens To Sue Covid-19 Vaccine Trial Participant; U.S. Agency Prepares For Covid-19 Vaccine Fraud
The Department of Homeland Security is working with dozens of drug companies racing to finalize and distribute Covid-19 vaccines and treatments to prepare for the scams that are coming.
STAT1 min lettiAmerican Government
STAT+: Pharmalittle: Biden Wins Biotech Support Despite His Policies; WHO Sets Covid-19 Compensation Fund For Low-income Nations
From a policy perspective, Joe Biden should be biotech’s worst nightmare. But that isn’t stopping major biotech chief executives and investors from personally backing Biden's campaign.